« Previous
Next »
Titles
- Interpretation of and compliance policy for certain label requirement: applicability of certain Federal Food, Drug, and Cosmetic Act requirements to vape shops2
- 30-Day notices, 135-day premarket approval (PMA) supplements and 75-day humanitarian device exemption (HDE) supplements for manufacturing method or process changes: guidance for industry and Food and Drug Administration staff1
- A report from the Forum session: implementing the Medicare prescription drug benefit : continuing challenges for states1
- Access to preventive services without cost-sharing: evidence from the Affordable Care Act1
- Affordable Care Act has led to historic, widespread increase in health insurance coverage1
- Affordable Care Act: IRS should mitigate limitations of data to be used for the age and gender adjustment for the tax on high-cost health plans : report to Congressional committees1
- An evaluation of CBO's past outlay projections1
- Analysis of 2017 premium changes and insurer participation in the Affordable Care Act's health insurance marketplaces1
- Annual status report information and other submissions for postmarketing requirements and commitments: using forms FDA 3988 and FDA 3989 : guidance for industry1
- Appropriate use of voluntary consensus standards in premarket submissions for medical devices: guidance for industry and Food and Drug Administration staff1
- Breakthrough Devices Program: guidance for industry and Food and Drug Administration staff1
- Building the Nation's health care workforce1
- CARES Act: experts identified safeguards to help selected HHS agencies protect against potential political interference : report to congressional requesters1
- CMS Innovation Center: model implementation and center performance : report to Congressional requesters1
- COVID-19: Agencies are taking steps to improve future use of Defense Production Act authorities : report to congressional committees1
- COVID-19: Selected states modified meal provision and other Older Americans Act services to prioritize safety : report to congressional addressees1
- Caring for "Ryan White": the fundamentals of HIV/AIDS treatment policy1
- Center for Devices and Radiological Health (CDRH) appeals processes: questions and answers about 517A : guidance for industry and Food and Drug Administration staff1
- Center for Devices and Radiological Health appeals processes: questions and answers about 517A : guidance for industry and Food and Drug Administration staff1
- Changes to existing medical software policies resulting from section 3060 of the 21st Century Cures Act: guidance for industry and Food and Drug Administration staff1